News
Nano One Appoints Carla Matheson as Independent Director
December 16, 2021. Vancouver, Canada. Nano One® Materials Corp. (TSX: NANO) (OTC-Nasdaq Intl Designation: NNOMF) (Frankfurt: LBMB) (“Nano One” or the “Company”), a clean technology company
Yumy Bear Goods Announces Partnership With One of Canadas Top Online Retailers Well.Ca
VANCOUVER, BC, December 16, 2021, Yumy Bear Goods Inc., (CSE: YUMY) ("Yumy Bear" or the "Company") has begun selling its low sugar "Better for You" candy on online Canadian retailer
Ketamine One Reports Strong 1Q22 Financial Results
REVENUES REACHED JUST UNDER $2.0 MILLION FOR THE QUARTER ENDED OCTOBER 31, 2021
Vancouver, British Columbia, December 16, 2021 – KetamineOne Capital Limited (“Ketamine One” or the
Volt Resources: Zavalievsky Graphite – Operations Update
15 December 2021
Highlights
- Volt provides working capital to Zavalievsky Graphite mid-November to recommence operations following implementation of governance and other chang
Volt Resources: Zavalievsky Graphite – Operations Update
15 December 2021
Highlights
- Volt provides working capital to Zavalievsky Graphite mid-November to recommence operations following implementation of governance and other chang
Gold Line Appoints Former Kirkland Lake Gold Vice President of Exploration, Douglas Cater, as Technical Advisor
Vancouver, BC, Canada – December 15, 2021 – Gold Line Resources Ltd. (TSX-V: GLDL, Frankfurt: 4UZ, WKN: A2QGWC, OTCQB: TLLZF) (“Gold Line” or the “Company”) is pleased to announce that it
Uranium Energy Corp Files Fiscal 2022 Q1 Quarterly Report
Corpus Christi, TX, December 15, 2021 - Uranium Energy Corp (NYSE American: UEC, the “Company” or “UEC” - https://www.commodity-tv.com/ondemand/companies/profil/uranium-energy-corp/) is
Cerro de Pasco Resources Announces Green Hydrogen Start-up
MONTRÉAL, QUÉBEC, CANADA — (December 15, 2021) Cerro de Pasco Resources Inc. (CSE:CDPR) (Frankfurt: N8HP) (“CDPR,” or the “Company“) is pleased to announce that CDPR and Prof Dr Bernhard Dold
GCM Mining Declares Monthly Dividend to Be Paid on January 17, 2022; Provides Updates on Production and Normal Course Issuer Bid for Its Common Shares
TORONTO, CANADA, Wednesday, December 15, 2021 – GCM Mining Corp. (“GCM Mining” or the “Company”) (TSX: GCM, OTCQX: TPRFF - https://www.commodity-tv.com/ondemand/companies/profil/gran-colombia
UniDoc Health CEO Message
This news release is not for distribution to U.S. newswire services for dissemination in the United States
.
- UDOC Provides Overview of Strategic Plan and Commercial Goals
-
Patriot Battery Metals Announces $11M Flow-Through Financing
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S
December 15, 2021 – Patriot Battery Metals Inc. (the “Company” or “Patriot”) (CSE: PMET) (OTCQB: RGDCF) (FSE:
DeFi Technologies Expands European Footprint and Announces Listing of Valour ETPs on Euronext Paris & Amsterdam
- Valour Bitcoin Zero (ISIN: CH0573883474) and Valour Ethereum Zero (ISIN: CH0585378752)) now available on Euronext exchanges
- Both products offered with zero management
Newcore Gold – Unlocking the Potential of the Enchi Gold Project in Ghana through Aggressive Exploration
- A Summary of Newcore Gold’s Achievements in 2021
December 15, 2021 - Vancouver, BC – Newcore Gold Ltd. ("Newcore" or the "Company") (TSX-V: NCAU, OTCQX: NCAUF) is pleased
Blackhawk Growth Announces Plan to Spin-Out Psychedelic Subsidiaries and Proposes 1:1 Distribution Ratio
Vancouver, British Columbia – December 15, 2021 – Blackhawk Growth Corp. (CSE:BLR; Frankfurt:0JJ) ( “Blackhawk”), is pleased to announce that it intends to undertake a spin-out transaction
Recce Pharmaceuticals: Patients to be Dosed in Phase I Intravenous Clinical Trial of RECCE® 327
Highlights:
- 10 healthy subjects recruited for Phase I human clinical trial
- Dosing in subjects will commence 16th December 2021
- R327 is the only clinical-stage
XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips
Vancouver, Canada, and Uttenweiler, Germany (December 15, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to provide an update on the
Billy Goat Brands Investee FunGuys Beverages Announces Operations, Distribution and Marketing Updates for its KOLD Line of Products
- The KOLD-Branded Bottle Design, Testing Phases, and E-Commerce Website are all Advancing Towards Completion
Vancouver, British Columbia - December 15, 2021 - Billy Goat Brands Ltd. (
EV Resources: Strategic Investment by Yahua
Highlights
- Yahua International Investment and Development Co. Ltd (“Yahua”) subscribes for 80m Ordinary shares in EV Resources Limited at A$0.045 per share, raising A$3.6m
Ketamine One Appoints Joe Ramelli as Its New Chief Financial Officer
Former CFO Amicably Departing the Company to Facilitate the Transition
Vancouver, British Columbia, December 14, 2021 - KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO:
Desert Gold Closes First Tranche of Non-Brokered Private Placement
Delta, British Columbia, December 13, 2021. Desert Gold Ventures Inc. (the “Company”) (TSX.V: DAU, FSE: QXR2, OTC: DAUGF) is pleased to announce that, subject to stock exchange approval, it
Defence Therapeutics Accum(TM) Boosts by 9-Fold the Delivery Effectiveness of the CRISPR/Cas9 Protein to Target Cells
Vancouver, BC, Canada, December 13th, 2021 - Defence Therapeutics Inc. (“Defence” or the “Company”), a biotechnology company focused on the development of vaccines and therapeutics against
Zacatecas Silver Reports its Initial Inferred Mineral Resource Estimate of 16.4 Million Silver Equivalent Ounces at 187 g/t AgEq at the Panuco Deposit Including a Zone of 5.1 Million Silver Equivalent Ounces at 235.25 AgEq
Zacatecas Silver Reports its Initial Inferred Mineral Resource Estimate of 16.4 Million Silver Equivalent Ounces at 187 g/t AgEq at the Panuco Deposit Including a Zone of 5.1 Million Silver
Defence Therapeutics Accumtm Boosts By 9-Fold the Delivery Effectiveness of the CRISPR/Cas9 Protein to Target Cells
Vancouver, BC, Canada, December 13th, 2021 - Defence Therapeutics Inc. (“Defence” or the “Company”), a biotechnology company focused on the development of vaccines and therapeutics against